FDA Inspection 1269921 - Revance Therapeutics, Inc. - May 01, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Revance Therapeutics, Inc., with an inspection on May 1, 2025, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Revance Therapeutics, Inc.
Inspection Date: May 1, 2025
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · be88cb67-1a16-4e2f-8531-a6c276fb6212